the aid library

LIST OPTIONS

Filter

4762

Population size estimate of people who inject drugs (PWID) in the Republic of Kazakhstan

Ganina L.Yu; Yelizaryeva A. V.; Saparbekov M. K.; et al. Ministry of Health and Social Development of the Republic of Kazakhstan Republican Center for AIDS Prevention and Control (2016) C2

Report Almaty, 2016 Authors: Ganina L.Yu., head of epidemiology department, Republican AIDS Center (RAC), Yelizaryeva A. V., epidemiologist, RAC, Kaspirova А. А., head of epidemiology department, Aktobe Oblast AIDS center, IvakinV.Yu., deputy regional director for strategic information, ICA... more

EU Guidelines for the prudent use of antimicrobials in human health

European Centre for Disease Prevention and Control (ECDC) (2017) C_CDC

These Guidelines on prudent use of antimicrobials in human health are based on a technical report prepared by the European Centre for Disease Prevention and Control (ECDC) with input from EU Member States experts ... stakeholders, which should be referred to for details of the methodology used in creating the guidelines as well as for additional references more

Download (149)

View PDF (189)

Tome medidas para controlar la tuberculosis (TB) si tiene el HIV

Centers for Disease Control and Prevention CDC (2022) C_CDC

Las personas con el VIH también corren el riesgo de contraer TB. Lea este folleto hoy para aprender sobre la TB y el VIH. Luego comparta lo que aprenda con su familia y sus amigos.

Download (629)

View PDF (1228)

Second National Tuberculosis Prevalence Survey

National Center for TB and Leprosy Control, Cambodia Ministry of Health (2012) C1

Download (670)

View PDF (953)

Namibia: Application for Registration of a Medicine

Ministry of Health and Social Services (MOHSS) (2014) C2

Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.

Download (501)

View PDF (1128)

India: Operational Guidelines for Mobile Medical Unit (MMUs)

Ministry of Health and Family Welfare, Government of India (2015) C1

Download (652)

View PDF (1072)

Management of Type 2 Diabetes. Training Manual

WHO Collaborating Centre for Capacity Building and Research in Community-based Noncommunicable Disease Prevention and Control, All India Institute of Medical Sciences (AIIMS), New Delhi, India. World Health Organization WHO, India (2019) C_WHO

WHO Package of Essential NCD Interventions (PEN) Accessed March 18,2019

Download (145)

View PDF (226)

Country overview: Uzbekistan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2

Download (154)

View PDF (201)

Biobehavioural Survey Guidelines - For Populations at risk for HIV

A. Abdul-Quader; M. Berry; T. Bingham; J. Burnett; et al. Centers for Diseases Control and Prevention; UNAIDS; World Health Organization; et al. (2017) C_WHO

Global HIV Strategic Information Working Group

Download (197)

View PDF (190)

Catalogue of interventions addressing vaccine hesitancy

European Centre for Disease Prevention and Control ECDC (2017) C1

This catalogue provides tools and information resources to support EU/EEA countries in addressing the challenging issue of vaccine hesitancy. The catalogue provides examples of practices that can serve as a resource for other countries. The project ... more

Lo que usted necesita saber sobre la infección de TB

Centers for Disease Control and Prevention CDC (2022) C_CDC

Tome medidas para asegurarse de que la infección de TB no avance a la enfermedad de TB. Lea este folleto para aprender a controlar su salud.

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more